Literature DB >> 2304146

Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.

I N Mbawuike1, H R Six, T R Cate, R B Couch.   

Abstract

A single intraperitoneal injection of pregnant mice with a monovalent Formalin-inactivated influenza A virus vaccine protected their offspring against a lethal challenge dose of the same influenza A virus H3N2, H2N2, and H1N1 subtypes, as well as against challenge with the other two subtypes. Degree of protection was vaccine dose related. Cross-fostering of neonates indicated that protection was conferred by breast milk antibodies. Serum virus-specific neutralizing antibodies in the mothers and neonates correlated with resistance to vaccine virus, but were detected against other subtypes only in a complement enhancement test or when high doses of vaccine were given.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2304146      PMCID: PMC249259     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses.

Authors:  A L Frank; R B Couch; C A Griffis; B D Baxter
Journal:  J Clin Microbiol       Date:  1979-07       Impact factor: 5.948

2.  Haemagglutination-inhibition antibodies against influenza A and influenza B in maternal and neonatal sera.

Authors:  N Masurel; J I de Bruijne; H A Beuningh; H J Schouten
Journal:  J Hyg (Lond)       Date:  1978-02

3.  Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women.

Authors:  D L Murray; D T Imagawa; D M Okada; J W St Geme
Journal:  J Clin Microbiol       Date:  1979-08       Impact factor: 5.948

4.  Inhibition of pathogenic effect of effector T cells by specific suppressor T cells during influenza virus infection in mice.

Authors:  F Y Liew; S M Russell
Journal:  Nature       Date:  1983 Aug 11-17       Impact factor: 49.962

5.  Increased influenza pneumonia mortality of mice adoptively immunized with node and spleen cells sensitized by inactivated but not live virus.

Authors:  T R Cate; N G Mold
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

6.  Age-related heterologous antibody responses to influenza virus vaccination.

Authors:  G R Noble; H S Kaye; A P Kendal; W R Dowdle
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

7.  Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant.

Authors:  C V Sumaya; R S Gibbs
Journal:  J Infect Dis       Date:  1979-08       Impact factor: 5.226

8.  Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice.

Authors:  S Z Wilson; V Knight; P R Wyde; S Drake; R B Couch
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

Review 9.  Considerations of the risk of influenza in children and indications for prophylaxis.

Authors:  W P Glezen
Journal:  Rev Infect Dis       Date:  1980 May-Jun

10.  Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells.

Authors:  T J Braciale; K L Yap
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  19 in total

1.  Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control.

Authors:  Jene Choi; Bonnie Nannenga; Oleg N Demidov; Dmitry V Bulavin; Austin Cooney; Cory Brayton; Yongxin Zhang; Innocent N Mbawuike; Allan Bradley; Ettore Appella; Lawrence A Donehower
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

2.  A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection.

Authors:  Yoshikazu Honda-Okubo; Annasaheb Kolpe; Lei Li; Nikolai Petrovsky
Journal:  Vaccine       Date:  2014-06-21       Impact factor: 3.641

3.  Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants.

Authors:  Isaac Benowitz; Daina B Esposito; Kristina D Gracey; Eugene D Shapiro; Marietta Vázquez
Journal:  Clin Infect Dis       Date:  2010-11-08       Impact factor: 9.079

4.  Susceptibility to Pneumocystis carinii infection: host responses of neonatal mice from immune or naive mothers and of immune or naive adults.

Authors:  B A Garvy; A G Harmsen
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Acquisition of maternal antibodies both from the placenta and by lactation protects mouse offspring from Yersinia pestis challenge.

Authors:  Zhizhen Qi; Haihong Zhao; Qingwen Zhang; Yujing Bi; Lingling Ren; Xuecan Zhang; Hanqing Yang; Xiaoyan Yang; Qiong Wang; Cunxiang Li; Jiyuan Zhou; Youquan Xin; Yonghai Yang; Huiying Yang; Zongmin Du; Yafang Tan; Yanping Han; Yajun Song; Lei Zhou; Pingping Zhang; Yujun Cui; Yanfeng Yan; Dongsheng Zhou; Ruifu Yang; Xiaoyi Wang
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

Review 6.  Heterosubtypic immunity to influenza A virus: where do we stand?

Authors:  Kristie M Grebe; Jonathan W Yewdell; Jack R Bennink
Journal:  Microbes Infect       Date:  2008-07-09       Impact factor: 2.700

7.  Transfer of antibody against Borrelia duttonii from mother to young in ddY mice.

Authors:  M G Morshed; M Yokota; T Nakazawa; H Konishi
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  High efficiency gene transfer to airways of mice using influenza hemagglutinin pseudotyped lentiviral vectors.

Authors:  Manij Patel; Angela M Giddings; John Sechelski; John C Olsen
Journal:  J Gene Med       Date:  2013-01       Impact factor: 4.565

9.  Protection against the mouse-adapted A/FM/1/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among H1 and H2 strains.

Authors:  Y Okuno; K Matsumoto; Y Isegawa; S Ueda
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

10.  DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

Authors:  Suzanne L Epstein; Terrence M Tumpey; Julia A Misplon; Chia-Yun Lo; Lynn A Cooper; Kanta Subbarao; Mary Renshaw; Suryaprakash Sambhara; Jacqueline M Katz
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.